3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Pancreatic Cancer
1
Interventions
Automobiles
3
fludarabine
2
Sirolimus
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Cyclophosphamide
2
trametinib
1
sonidegib
1
ripretinib
1
ribociclib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
keyhole-limpet hemocyanin
1
interferon gamma-1b
1
guadecitabine
1
fludarabine phosphate
1
Vorinostat
1
Topotecan
1
Tetrahydrouridine
1
Tetanus Toxoid
1
Stem Cell Transplantation
1
Simvastatin
1
Photochemotherapy
1
Oncolytic Virotherapy
1
Mesna
1
Melphalan
1
Interferon-gamma
1
Immunotherapy
1
Filgrastim
1
Dihematoporphyrin Ether
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neoplasms, Germ Cell and Embryonal
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled